The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports

$ABMD, $EEX, $MB, $NBL, $NTRS, $OAS, $OXY, $PGR, $RNR, $ONCE

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of the Street’s Key analysts outlook for main issues for Thursday, as follows:

Abiomed Inc. (NASDAQ:ABMD) was raised to Overweight from Equal Weight with a 496 price target at Morgan Stanley.

Emerald Expositions Events Inc. (NYSE:EEX) was raised to Buy from Neutral with a 15 price target at Goldman Sachs. The 52-wk trading range is 11.50 – 24.45 and the consensus target price is at 14.90.

MINDBODY Inc. (NASDAQ:MB) was downgraded to Neutral from Overweight and the price target was cut to 31 from 48 at JPMorgan. The 52-wk trading range is 28.70 – 45.50 and the consensus target price is at 44.77.

Noble Energy Inc. (NYSE:NBL) was raised to Outperform from Market Perform at Raymond James.

Northern Trust Corp. (NASDAQ:NTRS) was raised to Outperform from Market Perform with a 126 target price at Wells Fargo. Northern Trust has a 114.25 consensus analyst target, and its 52-wk trading range is 87.98 – 115.61.

Oasis Petroleum Corp. (NYSE:OAS) was raised to Hold from Sell with an 11 price target at SunTrust Robinson Humphrey. The 52-wk trading range is 7.31 – 14.57 and the consensus target price is at 16.53.

Progressive Corp. (NYSE:PGR) was raised to Overweight from Equal Weight with an 84 price target at Morgan Stanley. The 52-wk trading range is 50.14 – 72.72 and the consensus target price is at 73.00.

RenaissanceRe Holdings Ltd. (NYSE:RNR) analysts raised to Buy from Hold with a 150 price target at Deutsche Bank. The consensus target price is at 139.90.

Spark Therapeutics Inc. (NASDAQ:ONCE) Wedbush analysts raised it to Neutral from Underperform with a 40 price target. Raymond James raised Spark Therapeutics to Strong Buy from Outperform, and B. Riley raised it was to Buy from Neutral.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH